North America Unit Dose Manufacturing Market Size, Share & Trends Analysis Report By Sourcing (In-house, Outsourcing), By Product (Liquid Unit Dose, Solid Unit Dose), By End Use, By Country, And Segment Forecasts, 2025 - 2030

North America Unit Dose Manufacturing Market Size, Share & Trends Analysis Report By Sourcing (In-house, Outsourcing), By Product (Liquid Unit Dose, Solid Unit Dose), By End Use, By Country, And Segment Forecasts, 2025 - 2030


Ligation Devices Market Growth & Trends

The global ligation devices market size is expected to reach USD 1.8 billion by 2030 according to a new report by Grand View Research, Inc., registering a 7.0% CAGR from 2025 to 2030. The market is primarily driven by the increasing incidence of digestive system related diseases and increasing adoption of minimally invasive procedures. Technological advancements in the field of endoscopy which require ligation devices is also expected to drive the growth. Moreover, increasing healthcare spending in the field of gastrointestinal procedures is also fueling the market. Rise in the geriatric population prone to various digestive and chronic diseases is projected to contribute to the rising demand. According to the National Institutes of Health, in 2015, there were 617 million people over the age of 65 years and the number is projected to reach1.6 billion by 2050.

Increasing use of ligation devices in open surgeries such as coronary artery bypass, aortic valve replacement, and mitral valve replacement is expected to propel growth of the ligation devices market. According to the Society of Thoracic Surgeons Adult Cardiac Surgery Database, in U.S., 156,931 Coronary Artery Bypass Grafting (CABG) procedures were performed, in 2016. In addition, favorable reimbursement policies along with rising R&D expenditure is also adding to the growth of the market.

Ligation Devices Market Report Highlights
  • By product, accessories segment accounted for the largest market share in 2024, owing to low cost and high usage of the product
  • By applier, reusable appliers are projected to continue dominating in near future owing to the rising use in both minimally invasive and open procedures
  • By application, gastrointestinal and abdominal surgery segment captured the largest market share in 2018, owing to increasing prevalence of age-related digestive diseases
  • Based on procedure type, minimally invasive procedures segment accounted for the largest market share of more than 67.1% in 2024 and is expected to maintain its dominance during the forecast period
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. List of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. North America Unit Dose Manufacturing Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increased Adoption of Unit Doses
3.2.1.2. Benefits of Manufacturing Unit Doses Over Repackaging
3.2.1.3. Growing Outsourcing Activities
3.2.1.4. Technological Advancements in Unit Dose Manufacturing
3.2.1.5. Increasing Prevalence of Chronic Diseases and Demand for Personalized Medicine
3.2.2. Market Restraint Analysis
3.2.2.1. Challenges Associated with the Adoption of Manufactured Unit Doses
3.2.2.2. Compliance Issues with Outsourcing
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Market Analysis Tools
3.5.1. Porter’s Five Forces Analysis
3.5.2. PESTEL analysis
3.5.3. COVID-19 Impact Analysis
Chapter 4. North America Unit Dose Manufacturing Market: Sourcing Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. North America Unit Dose Manufacturing Market: Sourcing Movement Analysis
4.3. North America Unit Dose Manufacturing Market Estimates & Forecasts, by Sourcing, 2018 - 2030 (USD Million)
4.4. In-House
4.4.1. In-House Market Estimates & Forecasts, 2018 - 2030 (USD Million)
4.5. Outsourcing
4.5.1. Outsourcing Market Estimates & Forecasts, 2018 - 2030 (USD Million)
Chapter 5. North America Unit Dose Manufacturing Market: Product Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. North America Unit Dose Manufacturing Market: Product Movement Analysis
5.3. North America Unit Dose Manufacturing Market Estimates & Forecasts, by Product, 2018 - 2030 (USD Million)
5.4. Liquid Unit Dose
5.4.1. Liquid Unit Dose Market Estimates & Forecasts, 2018 - 2030 (USD Million)
5.5. Solid Unit Dose
5.5.1. Solid Unit Dose Market Estimates & Forecasts, 2018 - 2030 (USD Million)
5.6. Others
5.6.1. Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)
Chapter 6. North America Unit Dose Manufacturing Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. North America Unit Dose Manufacturing Market: End Use Movement Analysis
6.3. North America Unit Dose Manufacturing Market Estimates & Forecasts, by End Use, 2018 - 2030 (USD Million)
6.4. Independent Pharmacies
6.4.1. Independent Pharmacies Market Estimates & Forecasts, 2018 - 2030 (USD Million)
6.5. Long Term Care Facility
6.5.1. Long Term Care Facility Market Estimates & Forecasts, 2018 - 2030 (USD Million)
6.6. Hospitals
6.6.1. Hospitals Market Estimates & Forecasts, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Others Market Estimates & Forecasts, 2018 - 2030 (USD Million)
Chapter 7. North America Unit Dose Manufacturing Market: Country Estimates & Trend Analysis, by Sourcing, by Product, By End Use
7.1. Country Dashboard
7.2. Country Movement Analysis
7.3. North America
7.3.1. North America Unit Dose Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Regulatory Framework
7.3.2.4. U.S. Unit Dose Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Canada
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Regulatory Framework
7.3.3.4. Canada Unit Dose Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. Mexico
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Regulatory Framework
7.3.4.4. Mexico Unit Dose Manufacturing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.1.1. Market Leaders
8.1.2. Emerging Players
8.2. Company Market Position Analysis, 2024 (Company Heat Map Analysis)
8.3. Company Profiles
8.3.1. Catalent Inc.
8.3.1.1. Company Overview
8.3.1.2. Financial Performance
8.3.1.3. Service Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Unither Pharmaceuticals
8.3.2.1. Company Overview
8.3.2.2. Financial Performance
8.3.2.3. Service Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. Thermo Fisher Scientific
8.3.3.1. Company Overview
8.3.3.2. Financial Performance
8.3.3.3. Service Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Corden Pharma
8.3.4.1. Company Overview
8.3.4.2. Financial Performance
8.3.4.3. Service Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Mikart
8.3.5.1. Company Overview
8.3.5.2. Financial Performance
8.3.5.3. Service Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Tape Mark
8.3.6.1. Company Overview
8.3.6.2. Financial Performance
8.3.6.3. Service Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Renaissance Lakewood LLC
8.3.7.1. Company Overview
8.3.7.2. Financial Performance
8.3.7.3. Service Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Medical Packaging Inc
8.3.8.1. Company Overview
8.3.8.2. Financial Performance
8.3.8.3. Service Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. American Health Packaging
8.3.9.1. Company Overview
8.3.9.2. Financial Performance
8.3.9.3. Service Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. PCI Pharma Services
8.3.10.1. Company Overview
8.3.10.2. Financial Performance
8.3.10.3. Service Benchmarking
8.3.10.4. Strategic Initiatives
8.3.11. Amcor PLC
8.3.11.1. Company Overview
8.3.11.2. Financial Performance
8.3.11.3. Service Benchmarking
8.3.11.4. Strategic Initiatives
8.3.12. Bristol-Myers Squibb
8.3.12.1. Company Overview
8.3.12.2. Financial Performance
8.3.12.3. Service Benchmarking
8.3.12.4. Strategic Initiatives
8.3.13. AbbVie Inc.
8.3.13.1. Company Overview
8.3.13.2. Financial Performance
8.3.13.3. Service Benchmarking
8.3.13.4. Strategic Initiatives
8.3.14. Merck & Co. Inc.
8.3.14.1. Company Overview
8.3.14.2. Financial Performance
8.3.14.3. Service Benchmarking
8.3.14.4. Strategic Initiatives
8.3.15. Pfizer Inc.
8.3.15.1. Company Overview
8.3.15.2. Financial Performance
8.3.15.3. Service Benchmarking
8.3.15.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings